Stay updated on SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Sign up to get notified when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.

Latest updates to the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page
- Check6 days agoChange DetectedThe study record now includes a References section, and a sitewide NIH notice describes the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference0.6%

- Check13 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedThe study record history now includes the added 'Revision: v3.7.0' and the removed 'Revision: v3.6.6'. This indicates the record has been updated to a newer version.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry labeled v3.6.6 was added to the study's record history, signaling a recent sponsor update. The previous revision, v3.6.5, was removed from the visible history.SummaryDifference0.1%

- Check76 days agoChange DetectedThe References section was removed from the study record page, eliminating the list of cited sources from the history view.SummaryDifference0.1%

Stay in the know with updates to SAR444245 and Cemiplimab in Skin Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAR444245 and Cemiplimab in Skin Cancers Clinical Trial page.